InvestSMART

Emyria Limited (ASX: EMD) - Announcements

- Current share price for EMD : $0.032

ASX company news and announcements for Emyria Limited (EMD) are delayed by 20 minutes from the time of their release between 7.30am and 7.30pm EDT and are in PDF format. All Emyria Limited (EMD) ASX announcements deemed to be price sensitive will be highlighted with . If you are looking for ASX announcements for companies other than Emyria Limited (EMD), please use our Company Announcements tool to search across all ASX-listed companies.

Latest company announcements for Emyria Limited (EMD)

Market Cap ($m) Headline Release
date/time+
Price at
release+
Current
price+
Gain/Loss View
$26 Change of Director's Interest Notice 28 Nov 2022 8:15AM $0.190 $0.032 fallen by 83.16%
$26 Notification regarding unquoted securities - EMD 25 Nov 2022 12:16PM $0.190 $0.032 fallen by 83.16%
$26 Notification regarding unquoted securities - EMD 25 Nov 2022 12:09PM $0.190 $0.032 fallen by 83.16%
$26 Placement completion and secondary trading notice 23 Nov 2022 10:00AM $0.185 $0.032 fallen by 82.70%
$26 Investor Presentation 23 Nov 2022 9:55AM $0.185 $0.032 fallen by 82.70%
$26 Notification regarding unquoted securities - EMD 23 Nov 2022 9:37AM $0.185 $0.032 fallen by 82.70%
$26 Application for quotation of securities - EMD 23 Nov 2022 9:34AM $0.185 $0.032 fallen by 82.70%
$26 Notification of cessation of securities - EMD 18 Nov 2022 6:57PM $0.185 $0.032 fallen by 82.70%
$26 Amended Constitution 17 Nov 2022 10:36AM $0.190 $0.032 fallen by 83.16%
$26 Appendix 4C - Quarterly 31 Oct 2022 2:53PM $0.215 $0.032 fallen by 85.12%
$26 Proposed issue of securities - EMD 31 Oct 2022 10:11AM $0.210 $0.032 fallen by 84.76%
$26 Proposed issue of securities - EMD 31 Oct 2022 10:11AM $0.210 $0.032 fallen by 84.76%
$26 Proposed issue of securities - EMD 31 Oct 2022 10:11AM $0.210 $0.032 fallen by 84.76%
$26 Emyria completes $3m placement 31 Oct 2022 10:11AM $0.210 $0.032 fallen by 84.76%
$26 Trading Halt 27 Oct 2022 9:39AM $0.210 $0.032 fallen by 84.76%
$26 Results of Meeting 25 Oct 2022 3:24PM $0.200 $0.032 fallen by 84%
$26 Emyria and UWA expand unique MDMA-inspired analogue library 18 Oct 2022 9:03AM $0.215 $0.032 fallen by 85.12%
$26 MDMA-inspired drug discovery presentation 13 Oct 2022 9:43AM $0.215 $0.032 fallen by 85.12%
$26 Emyria Investor Webinar - October 13 10 Oct 2022 9:31AM $0.220 $0.032 fallen by 85.45%
$26 Emyria expands clinical sites for EMD-RX5 Phase 3 trial 26 Sep 2022 8:18AM $0.225 $0.032 fallen by 85.78%
$26 Letter to Shareholders - Annual General Meeting 23 Sep 2022 5:45PM $0.225 $0.032 fallen by 85.78%
$26 Notice of Annual General Meeting/Proxy Form 23 Sep 2022 5:43PM $0.225 $0.032 fallen by 85.78%
$26 Emyria commences US preclinical program for MDMA library 19 Sep 2022 9:50AM $0.225 $0.032 fallen by 85.78%
$26 Annual General Meeting 31 Aug 2022 9:35AM $0.255 $0.032 fallen by 87.45%
$26 Annual Report to Shareholders 30 Aug 2022 10:47AM $0.255 $0.032 fallen by 87.45%

326 - 350 of 583 results

Page 14 of 24

  • + Company announcements and prices are delayed by least 20 minutes. Prices are indicative only.

DISCLOSURE: InvestSMART Group Limited employees may have an interest in the securities and managed funds displayed via this service. Please refer to our Financial Services Guide for more information.

Data shown on this website is sourced by Morningstar
© Morningstar. All rights reserved. Neither any Morningstar company nor any of their content providers guarantee the data or content contained herein to be accurate, complete or timely nor will they have any liability for its use or distribution. Any general advice has been prepared by Morningstar Australasia Pty Ltd (ABN: 95 090 665 544, AFSL: 240892) and/or Morningstar Research Limited, subsidiaries of Morningstar, Inc, without reference to your objectives, financial situation or needs. You should consider the advice in light of these matters and, if applicable, the relevant Product Disclosure Statement (in respect of Australian products) or Investment Statement (in respect of New Zealand products) before making any decision to invest. No Morningstar-affiliated company or any of their employees is providing you with personalised financial advice. To obtain advice tailored to your particular circumstances, please contact a professional financial adviser. Some material is copyright and published under licence from ASX Operations Pty Limited ACN 004 523 782 ("ASXO"). Data and content is provided for personal use only.